Relapsing-remitting Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing-remitting Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: MS Relapses During COVID-19 Pandemic
A completed clinical trial studying relapses in multiple sclerosis during the COVID-19 pandemic.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis [Phase 4]
A Phase 4 clinical trial evaluating Ublituximab (Briumvi) for early forms of relapsing multiple sclerosis is currently recruiting. Sponsored…
-
EMA approval · 2026-03-10EMA Authorised: Ponvory (ponesimod) — Laboratoires Juvisé Pharmaceuticals
The European Medicines Agency authorised Ponvory (ponesimod) for relapsing-remitting multiple sclerosis, with Laboratoires Juvisé Pharmaceut…
-
EMA approval · 2026-03-06EMA Authorised: Tyruko (natalizumab) — Sandoz GmbH
The European Medicines Agency authorised Tyruko, a natalizumab biosimilar by Sandoz GmbH, for treatment of multiple sclerosis including the …
-
EMA approval · 2026-03-02EMA Authorised: Fingolimod Accord (fingolimod hydrochloride) — Accord Healthcare S.L.U.
The EMA authorised Fingolimod Accord (fingolimod hydrochloride) from Accord Healthcare S.L.U. for relapsing-remitting multiple sclerosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls. [Phase 4]
A Phase 4 clinical trial evaluating the effect of ofatumumab in treatment-naïve, very early relapsing-remitting multiple sclerosis patients.…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis [Phase 3]
Phase 3 clinical trial update evaluating IMU-838 (vidofludimus) for relapsing-remitting multiple sclerosis; currently active but not recruit…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: The Synergistic Effects of AIH and FES in Persons With MS [NA]
This clinical trial update covers a study evaluating the synergistic effects of AIH and Functional Electrical Stimulation (FES) in people wi…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial evaluating dendritic cell therapy combined with immunomodulatory treatment for Relapsing-Remitting Multiple Scleros…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
A completed non-interventional study evaluating ocrelizumab in participants with relapsing-remitting or primary progressive multiple scleros…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Assessment of Attentional and Executive Disorders in Multiple Sclerosis Using Techniques of Virtual Reality [NA]
This clinical trial update notes that a study examining attentional and executive disorders in relapsing-remitting multiple sclerosis using …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Effects of Ublituximab on Motor Functions in Multiple Sclerosis [EARLY_Phase 1]
An early-phase 1 trial is evaluating the effects of ublituximab on motor function in relapsing-remitting multiple sclerosis and is currently…
-
EMA approval · 2026-02-05EMA Authorised: Kesimpta (ofatumumab) — Novartis Europharm Limited
The European Medicines Agency authorised Kesimpta (ofatumumab) for Relapsing-Remitting Multiple Sclerosis, with Novartis Europharm Limited a…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis [Phase 3]
This document describes a Phase 3 pediatric trial comparing ozanimod to fingolimod in children and adolescents with relapsing-remitting mult…
-
CLINICAL_TRIALS other · 2026-02-04Clinical Trial Update: Efficacy and Safety of Yishen Daluo Yin Granule for Relapsing-Remitting Multiple Sclerosis [NA]
Clinical trial update describing a study of Yishen Daluo Yin Granule for relapsing-remitting multiple sclerosis; the trial status is NOT_YET…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis [Phase 1]
Phase 1 trial evaluating fecal microbiota transplantation with FMP30 for relapsing-remitting multiple sclerosis has been terminated with res…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis. [Phase 3]
Phase 3 clinical trial comparing Rituximab versus Ocrelizumab for relapsing-remitting multiple sclerosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS) [Phase 3]
Clinical trial update describing a Phase 3 study comparing ocrelizumab with fingolimod for safety and efficacy in children and adolescents w…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis [NA]
A clinical trial investigating indole-3-propionic acid for relapsing-remitting multiple sclerosis is currently recruiting in Copenhagen. Spo…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: MS Synchronous vs Asynchronous Exercise Study [NA]
This clinical trial update notes completion of a study comparing synchronous versus asynchronous exercise in people with Multiple Sclerosis,…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Home Based Functional Balance Intervention for Multiple Sclerosis [NA]
A clinical trial is recruiting to evaluate a home-based functional balance intervention for people with multiple sclerosis. The study appear…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
A clinical trial update for a study evaluating the usability and value of integrated digital solutions in the care of participants with Rela…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis [NA]
A completed clinical trial sponsored by Cairo University evaluated the effect of probiotic therapy on relapsing-remitting multiple sclerosis…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) [Phase 3]
BEAT-MS is a Phase 3 trial comparing best available therapy to autologous hematopoietic stem cell transplantation for multiple sclerosis; it…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis [Phase 3]
This document reports an ongoing Phase 3 clinical trial evaluating the efficacy and safety of BCD-281 for relapsing-remitting multiple scler…